Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Paltusotine received Orphan Drug Designation for the treatment of acromegalyHalf of the enrolled patients in the ongoing Phase 2 ACROBAT […]
Iovance Biotherapeutics to Present at BTIG Biotechnology Conference 2020
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]
Ebix Reports $28.8M of Operating Cash Flow Despite COVID-19
JOHNS CREEK, Ga., Aug. 07, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), today announced the following results for the […]
Imara to Webcast Conference Call of Second Quarter 2020 Financial Results
BOSTON, Aug. 07, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing […]
Gaming and Leisure Properties, Inc. Declares Third Quarter 2020 Dividend of $0.60 Per Share
WYOMISSING, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (the “Company”), announced today that […]
Surgalign Holdings, Inc. Announces Second Quarter 2020 Results
DEERFIELD, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused […]
BioXcel Therapeutics to Host Second Quarter 2020 Operating and Financial Results Conference Call and Webcast
NEW HAVEN, Conn., Aug. 07, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]
Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference
NEW HAVEN, Conn., Aug. 07, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights
WAYNE, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing […]
Altimmune Completes Enrollment in Phase 1b Clinical Trial of NasoShield™, a Single Dose Intranasal Anthrax Vaccine Candidate
GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
